Detailed Information on Publication Record
2013
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
PILÁTOVÁ, Kateřina, Kristína GREPLOVÁ, Regina DEMLOVÁ, Beatrix BENCSIKOVÁ, Giannoula Lakka KLEMENT et. al.Basic information
Original name
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
Authors
PILÁTOVÁ, Kateřina (203 Czech Republic, belonging to the institution), Kristína GREPLOVÁ (203 Czech Republic, belonging to the institution), Regina DEMLOVÁ (203 Czech Republic, belonging to the institution), Beatrix BENCSIKOVÁ (703 Slovakia, belonging to the institution), Giannoula Lakka KLEMENT (840 United States of America) and Lenka ZDRAŽILOVÁ DUBSKÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition
Journal of Hematology & Oncology, LONDON, BIOMED CENTRAL LTD, 2013, 1756-8722
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.933
RIV identification code
RIV/00216224:14110/13:00069034
Organization unit
Faculty of Medicine
UT WoS
000321009900001
Keywords in English
Platelet; PF-4; CTAP-III; Cancer; Angiogenesis; IL-8; Inflammation
Tags
International impact, Reviewed
Změněno: 18/4/2014 10:13, Ing. Mgr. Věra Pospíšilíková
Abstract
V originále
With the recent addition of anti-angiogenic agents to cancer treatment, the angiogenesis regulators in platelets are gaining importance. Platelet factor 4 (PF-4/CXCL4) and Connective tissue activating peptide III (CTAP-III) are two platelet-associated chemokines that modulate tumor angiogenesis, inflammation within the tumor microenvironment, and in turn tumor growth. Here, we review the role of PF-4 and CTAP-III in the regulation of tumor angiogenesis; the results of clinical trial using recombinant PF-4 (rPF-4); and the use of PF-4 and CTAP-III as cancer biomarkers.